High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection
Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Syed Ziauddin A. Zaidi(Holy Family Hospital), Naeem Chaudhri(King Faisal Specialist Hospital & Research Centre), Mohammad Bakr(King Faisal Specialist Hospital & Research Centre), Zubeir Nurgat(King Faisal Specialist Hospital & Research Centre), Amr Nassar(Jouf University), Walid Rasheed(King Faisal Specialist Hospital & Research Centre), Khaled Ibrahim(King Faisal Specialist Hospital & Research Centre), Fahad Al Rabiah(King Faisal Specialist Hospital & Research Centre), Hail Al Abdely(King Faisal Specialist Hospital & Research Centre), Moosa Patel, Fahad Al Sharif(King Faisal Specialist Hospital & Research Centre), Shad Ahmed(King Faisal Specialist Hospital & Research Centre), Hazzaa Al Zahrani(King Faisal Specialist Hospital & Research Centre), Said Mohamed(King Faisal Specialist Hospital & Research Centre), Fahad Al Mohareb(King Faisal Specialist Hospital & Research Centre)
Cited by 15
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434